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Neonatal and adult neutrophils are distinctly different from one another due to 
well-defined and documented deficiencies in neonatal cells, including impaired 
functions, reduced concentrations of microbicidal proteins and enzymes neces-
sary for pathogen destruction, and variances in cell surface receptors. Neutrophil 
maturation is clearly demonstrated throughout pregnancy from the earliest hema-
topoietic precursors in the yolk sac to the well-developed myeloid progenitor cells 
in the bone marrow around the seventh month of gestation. Notable deficiencies 
of neonatal neutrophils are generally correlated with gestational age and clinical 
condition, so that the least functional neutrophils are found in the youngest, sickest 
neonates. Interruption of normal gestation secondary to preterm birth exposes 
these shortcomings and places the neonate at an exceptionally high rate of infection 
and sepsis-related mortality. Because the fetus develops in a sterile environment, 
neonatal adaptive immune responses are deficient from lack of antigen exposure 
in utero. Newborns must therefore rely on innate immunity to protect against early 
infection. Neutrophils are a vital component of innate immunity since they are the 
first cells to respond to and defend against bacterial, viral, and fungal infections. 
However, notable phenotypic and functional disparities exist between neonatal and 
adult cells. Below is review of neutrophil ontogeny, as well as a discussion regarding 
known differences between preterm and term neonatal and adult neutrophils with 
respect to cell membrane receptors and functions. Our analysis will also explain 
how these variations decrease with postnatal age.
Keywords: neonates, neutrophils, granulopoiesis, innate immunity, phagocytosis, chemotaxis, neutrophil 
extracellular traps, transmigration
Abbreviations: AP, adaptor protein complex; BPI, bactericidal/permeability-increasing protein; CGD, chronic granulomatous 
disease; CL, chemiluminescence; EOS, early-onset sepsis; fMLP, N-formylmethionine-leucyl-phenylalanine; GA, gestational 
age; GBS, group B Streptococcus; GGA, Golgi-localized γ-adaptin ear homology ARF-binding protein; G-CSF, granulocyte 
colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; HIF, hypoxia-inducible factor; HSC, 
hematopoietic stem cell; ICAM, intercellular adhesion molecule; IVIG, intravenous immunoglobulin; LAD, leukocyte adhe-
sion deficiency; LPS, lipopolysaccharide; LFA-1, lymphocyte function-associated antigen-1; NET, neutrophil extracellular 
trap; nNIF, NET-inhibitory factors; NBT, nitroblue tetrazolium; NRP, nHIF-related peptides; PMA, phorbol myristate acetate; 
RAGE, receptor for advanced glycation endproducts; ROS, reactive oxygen species; SGA, small for gestational age; SNARE, 
soluble N-ethylmaleimide-sensitive factor attachment protein receptor; TLR, toll-like receptor; VCAM-1, vascular cell adhe-
sion molecule 1.
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iNTRODUCTiON
The creation of life through human pregnancy is an astonishing 
achievement of nature, by which the allogeneic fetus is protected 
from maternal rejection through placental separation of fetal 
and maternal vascular systems as well as immunosuppression 
resulting from high levels of maternal progesterone and placental 
production of glucocorticoids (1). Intriguingly, this protection 
ensues even if the fetus is genetically diverse from its carrier, 
as observed with surrogate pregnancies, indicating a similarly 
tolerant fetus. Although suppressed, maternal immunity pro-
vides primary protection to the developing fetus against in utero 
infections and helps safeguard the newborn during the first year 
of life. This protection is achieved not only through placental 
transport of maternal immunoglobulins during the last trimester 
of pregnancy (2) but also by the newborn’s consumption of breast 
milk, rich in antimicrobial proteins, immunoglobulins, and ben-
eficial oligosaccharides (3). If maternal defenses are breeched by 
pathogens, resulting in chorioamnionitis or neonatal infection, a 
detrimental inflammatory cascade may be initiated in the neonate 
with the potential for devastating long-term neurodevelopmental 
sequelae (4, 5) and/or perturbations in the normal development 
of the immune system (6).
Because the fetus develops in a sterile milieu, neonatal adap-
tive immune responses are naïve from lack of antigen exposure 
in  utero. Newborns must, therefore, rely on innate immunity 
to protect against early infection (7–9). Neutrophils are a vital 
component of innate immunity because they are the first circu-
lating immune cells to respond to and defend against bacterial, 
viral, and fungal infections. However, notable phenotypic and 
functional disparities exist between neonatal and adult cells. The 
severity of these impairments is inversely related to gestational 
age (GA), revealing progressive neutrophil maturation through-
out pregnancy, from the earliest hematopoietic precursors in the 
yolk sac to the well-developed myeloid progenitor cells in the 
bone marrow around the seventh month of pregnancy. These 
deficiencies place our most vulnerable patients at risk for infec-
tion and sepsis-related mortality.
Environmental factors also directly impact neutrophil pheno-
type and function, and differ considerably between the maturing 
fetus and adult. The intrauterine environment is exceedingly 
hypoxic with oxygen concentrations measured in the range of 
1–5%, compared to 21% in the Earth’s atmosphere. This low 
oxygen content necessitates cellular suppression mechanisms 
to counteract hypoxia-inducible factor 1α (HIF-1α)-mediated 
pro-inflammatory gene expression. Similarly, immune tolerance 
is vital during and after parturition, when the neonate is newly 
exposed to trillions of microorganisms that will become impor-
tant components of its healthy microbiome.
For more than 50 years, scientists have been striving to under-
stand the intrinsic mechanisms underpinning the normal transi-
tion of the suppressed in utero neutrophil into the fully functional 
postpartum cell capable of combating pathogenic organisms. This 
quest is even more urgent for extremely premature neonates, 
who are born at the limits of viability, and join the world before 
the immune developmental program is properly executed. As a 
consequence, these vulnerable neonates experience a profound 
compromise of both innate and adaptive immune responses. In 
this review, we explore differences between neonatal and adult 
neutrophils, describe neutrophil maturation throughout preg-
nancy, and highlight therapies trialed in neonates to enhance 
neutrophil function.
DeveLOPMeNT
Hematopoiesis
Fetal hematopoiesis, or the creation of all blood cells, is an evolu-
tionarily conserved process that originates in the extra-embryonic 
yolk sac around the third week of embryogenesis and gives rise to 
a transient population of primeval erythroid cells, macrophages, 
and megakaryocytes (10, 11). Around the seventh to eighth week 
of gestation, genuine hematopoietic stem cells (HSCs) are derived 
from specialized intra-embryonic endothelial cells located in the 
ventral wall of the descending aorta (12–14). These self-renewing 
primitive HSCs, with increased proliferation potential (15), will 
seed the liver, thymus, and spleen, where hematopoiesis will 
continue until the seventh month of gestation (10, 16). After this 
time, hematopoiesis will transition to the bone marrow, such 
that by the end of term gestation, the bone marrow becomes the 
primary source of red cells, white cells, and platelets (17, 18).
Neutrophils first appear in the human clavicular marrow at 
10–11 weeks post conception (19). By the end of the first trimester, 
neutrophil precursors are detected in the peripheral blood, while 
mature cells appear by 14–16 weeks of fetal development (20, 21). 
HSCs that generate neutrophils are situated in specialized niches 
in the trabecular regions of long bones near the endosteum, or 
the interface between the bone and bone marrow, in proximity to 
osteoblasts (22–24). To exit the bone marrow, neutrophils must 
traverse the bone marrow endothelium through tight-fitting 
pores by a process known as transcellular migration, whereby the 
cells pass through the cell bodies of the endothelium rather than 
through cell junctions (25, 26).
Neutrophils reside in three different groups, or pools, known 
as the proliferative, circulating, and marginating pools, with 
numbers in each influenced by the maturational development of 
the cell and the individual’s state of health. A delicate balance 
between neutrophil maturation, bone marrow storage and release, 
intravascular margination, and migration into peripheral tissues 
is closely regulated by conventional dendritic cells through the 
controlled production of granulocyte colony-stimulating factor 
(G-CSF), CXCL1, CCL2, and CXCL10 (27).
Proliferative Bone Marrow Pool
The proliferative pool comprised mitotic neutrophil precursors, 
including myeloblasts, promyelocytes, and myelocytes, which 
maintain their ability to multiply in order to replenish neutrophil 
numbers (28, 29). In human adults, the proliferative pool is esti-
mated to contain between 4 and 5 × 109 cells/kg bodyweight (30, 
31). In term neonates, however, this pool is greatly diminished 
at only 10% of adult values, with more than two-thirds of their 
cells residing in an active cell cycle, resulting in substantial cell 
turnover (20, 32). The absolute neutrophil cell mass per gram 
body weight in term neonates is also considerably less, calculated 
TABLe 1 | variances between neonatal and adult neutrophils.
variable Preterm Term Matures Comment
Neutrophil cell 
mass (per gram 
BW)
↓↓ ↓ Yes Adult levels achieved by 
4 weeks of age (20, 34)
Storage pool ↓↓ ↓ Yes Reduced storage pools lead to 
increased risks for neutropenia 
if infection occurs postnatally 
(20, 37)
Number in 
circulation
↑/↑ ↑ Yes Increases noted for all 
gestational age (GA) infants 
in the first 24 h after birth. 
Quantities return to adult levels 
by 72 h of life. The highest 
levels are found in neonates 
<28 weeks of GA (64)
Number of IG in 
circulation
↑ ↑ Unknown Neutrophil composition 
approximates that of adults by 
72 h of life (65, 90)
Granule protein 
levels
 BPI ↓↓ ↓ Yes (68)
 Lactoferrin ↓↓ ↓ Yes (75)
Chemotaxis ↓ ↓ No Factors include reduced 
mobilization of intracellular 
calcium (88) and anomalies in 
cytoskeletal organization (89)
Rolling and firm 
adhesion
  L-selectin 
levels
↓↓ ↓ Yes (8, 93)
  L-selectin 
shedding
↓↓ ↓ Yes (8, 93)
 CR3 ↓↓ ↓ Yes (38, 93)
Transmigration ↓↓ ↓ Yes Decreased secondarily 
to reduced levels of CR3 
and diminished release of 
chemokines and cytokines 
from tissue neutrophils and 
macrophages (38, 93)
Neutrophil 
extracellular 
trap (NET) 
production
↓↓ ↓ Yes Neonatal neutrophils only 
produce NETs in a ROS-
independent manner (152, 
153, 157)
↑, increased; ↓, decreased; IG, immature granulocyte; BPI, bactericidal permeability-
increasing protein.
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to be only one-fourth that of adult levels (33), while preterm 
infants <32 weeks of gestation exhibit even lower values (~20% 
adult numbers) (34) (Table 1).
Neutrophils are activated from the early phases of bloodstream 
or deep tissue infection, causing their numbers in circulation to 
rapidly rise (35). Hence, bone marrow reserves of mature neutro-
phils are rapidly depleted due to limited stores, necessitating the 
release of immature granulocytes (IGs), known as a “left shift,” 
which is often used to assess a person’s probability of serious 
infection or sepsis (36). Because newborns, particularly very low 
birth weight premature neonates, have an exceptionally limited 
ability to recruit or generate significant neutrophil numbers, 
they are more likely to develop neutropenia when confronted 
by a pathogenic challenge, thereby increasing sepsis-associated 
morbidity and mortality (16, 20, 37). By contrast, adults maintain 
a large number of quiescent neutrophil progenitors that can be 
rapidly recruited into the cell cycle during times of sepsis (16, 20, 
37, 38), coupled to a sizable bone marrow reserve of near-mature 
and mature neutrophils that can be quickly mobilized in early 
inflammatory responses (20 times that found in circulation) (30). 
Ultimately, neutrophil numbers in term and preterm infants will 
rise over the first few weeks of life to achieve adult values by 
4 weeks of age (34).
Diminished Neutrophil Production and 
Neonatal Neutropenia
Neonates who are small for gestational age (SGA) at birth, or 
have a birthweight <10th percentile, also have higher rates of 
neutropenia (absolute neutrophil count of <1,000/mL) compared 
to non-SGA infants, with an incidence of 6 vs. 1%, respectively. 
SGA neutropenia usually persists for the first week of life and is 
associated with thrombocytopenia in more than 60% of neonates 
(39). Previous conclusions of a direct correlation between neutro-
penia and preeclampsia (40), or related placental deficiency, have 
since been disproven with regression models demonstrating no 
higher incidence of low neutrophil counts over and above that 
calculated for SGA alone (39, 41). SGA neutropenia most likely 
results from in utero growth restriction rather than high maternal 
blood pressure because the severity of neutropenia is directly cor-
related with the number of circulating nucleated red blood cells 
(39). Diminished neutrophil production, rather than accelerated 
neutrophil destruction or excessive margination, is considered 
the primary mechanism underlying this phenomenon, as a 
normal immature to total (I:T) neutrophil ratio is maintained 
(39). Additionally, findings of decreased neutrophil production 
from pluripotent hematopoietic progenitors, reduced concentra-
tions of granulocyte-macrophage progenitors, diminished bone 
marrow neutrophil proliferative and storage pools, and absence 
of evidence for excessive margination have been found in experi-
mental models (40). Impaired neutrophil production is therefore 
thought to result from (1) downregulation of neutrophil growth 
or transcription factors due to high concentrations of erythro-
poietin (42), (2) inadequate G-CSF production, or (3) a placental 
inhibitor of neutrophil production that has yet to be identified 
(39). Notably, neutropenic SGA infants have an increased prob-
ability of being diagnosed with late-onset sepsis, as well as a 
fourfold increased risk of developing necrotizing enterocolitis 
for reasons that remain unclear (39).
Intriguingly, extremely low birth weight (ELBW) infants, 
or those born less than 1,000 g at birth, experience the highest 
frequency of neutropenia of any other neonatal group without 
an identified cause (43). Unlike older gestational aged neonates, 
neutropenia in ELBW infants is usually not associated with sepsis 
(44). Therefore, ELBW infants with and without neutropenia 
experience similar mortality rates in the NICU (43).
Trials investigating the clinical use of recombinant G-CSF and 
granulocyte-macrophage colony-stimulating factor (GM-CSF) 
to increase neutrophil numbers in preterm infants have yielded 
disappointing results, granted that sample sizes have been small. 
FigURe 1 | Neutrophil granulopoiesis. Neutrophil maturation is defined by the sequential formation of three different granules and secretory vesicles, as well as 
nuclear segmentation. Granulopoiesis begins with the development of azurophilic granules in myeloblasts/promyelocytes and concludes after creation of secretory 
vesicles in mature, segmented cells. Azurophilic granules, which contain acidic hydrolases and microbicidal proteins, fuse with phagosomes to form highly toxic 
enclosures for oxidative reactions, necessary for pathogen destruction. Specific granules participate in both extracellular and intracellular microbial killing and are rich 
in antibiotic substances. Gelatinase granules are mobilized when the neutrophil establishes rolling contact with inflamed endothelium and contain matrix-degrading 
enzymes (gelatinase) and membrane receptors. Secretory vesicles are the first to be mobilized after minimal neutrophil stimulation and contain membrane-
associated receptors that are key for chemotactic-directed migration and the establishment of firm contact with activated vascular endothelium.
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Although both drugs increased overall neutrophil numbers, no 
differences in mortality were observed by day 14 from the start 
of therapy in preterm infants with suspected or proven systemic 
infection who received concurrent antibiotic therapy (45, 46). The 
PROGRAMS trial, which specifically studied the prophylactic use 
of GM-CSF in SGA preterm infants in the first 5 days of life, also 
found no benefit in sepsis-free survival to day 14 from trial entry 
compared to the control group (47). In this study, GM-CSF was 
preferentially chosen because of its ability to illicit a TH1 immune 
response, prime neutrophils and monocytes to enhance bacte-
ricidal activity, and stimulate proliferation of neutrophil pro-
genitors. A subgroup analysis by the Cochrane Group, however, 
identified 97 preterm infants from three studies, who suffered 
from both neutropenia and systemic infection at time of enroll-
ment and received either drug. Remarkably, this defined group 
experienced a significant reduction in mortality by day 14 [RR 
0.34 (95% CI 0.12–0.92); NNT 6 (95% CI 3–33)] (46), signifying 
that further appropriately powered studies should be undertaken 
to determine efficacy in this specific patient population (48).
granulopoiesis
Neutrophil development is defined by the formation of granules 
within the maturing cell, known as granulopoiesis. This process 
begins between the myelocyte and promyelocyte stages of devel-
opment and proceeds over the subsequent 4–6 days to produce 
mature, segmented neutrophils (Figure 1) (49–51). Formation of 
neutrophil granules occurs in a continuum by a process known 
as “targeting by timing,” whereby granule proteins are sequentially 
packaged as they are produced, so that azurophilic granules 
are synthesized in promyelocytes, specific granule proteins in 
myelocytes, and gelatinase granule proteins in metamyelocytes 
and band cells, after which granule formation concludes and 
secretory vesicles form (50, 52–54). Recent findings reveal that 
direct sorting of granule components is also imperative for 
proper neutrophil granule formation. This is exemplified by the 
proteoglycan serglycin, which is essential for the shuttling and 
packaging of α-defensin and elastase into azurophilic granules 
(55–57). Additionally, the discovery of adaptor protein complexes 
and the monomeric Golgi-localized γ-adaptin ear homology ARF 
(GGA)-binding protein have shown that together, these sub-
stances recognize, organize, and traffic granule proteins from the 
trans-Golgi network to their respective granule compartments 
based on complex co- and posttranslational processing similar to 
that of lysosomal sorting of other cell types (58, 59).
Neutrophil granules are exocytosed in the reverse order of 
their formation in a hierarchical fashion based on the function 
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of their contents and the magnitude of the stimulus (50, 51, 60). 
Thus, secretory vesicles are the first to be extruded after minimal 
cellular stimulation or activation. Although not considered a true 
neutrophil granule, secretory vesicles are mobilized in the earliest 
stages of neutrophil-mediated inflammatory responses and are 
vital reservoirs of membrane-associated receptors that allow 
the neutrophil to establish firm contact with activated vascular 
endothelium and transmigrate into inflamed tissues. Gelatinase 
granules follow and contain matrix-degrading enzymes (gelati-
nases) and membrane receptors that are important for extravasa-
tion into inflamed tissues during early inflammatory processes. 
Specific granules are mobilized next and release their antimi-
crobial contents extracellularly or discharge their substances 
into phagosomes. Phagosomes provide lethal enclosures for the 
intracellular killing of phagocytosed microorganisms through 
the creation of confined spaces that allow for exposure to high 
concentrations of microbicidal proteins and hydrolytic enzymes. 
Azurophilic granules are the last to be mobilized and are unique 
among the neutrophil granules because they can only degranulate 
their contents into phagosomes after activation by very powerful 
stimuli. Because azurophilic granules contain acidic hydrolases 
and microbicidal proteins that can be harmful to surrounding 
tissues if released extracellularly, close regulation is necessary. 
Recently identified variations in soluble N-ethylmaleimide-
sensitive factor attachment protein receptor (SNARE) complexes 
explain these differences: whereas all neutrophil granules contain 
syntaxin 4 and SNARE complexes within their membranes, spe-
cific and gelatinase granules have SNARE complexes with high 
concentrations of VAMP-1, VAMP-2, and 23-kDa synaptosome-
associated protein 23, while azurophilic granules have increased 
levels of VAMP-1 and VAMP-7 (61, 62).
Circulating and Marginating 
Neutrophil Pools
More mature neutrophils that reside outside of the proliferative 
pool (metamyelocytes, bands, and segmented cells) are found 
in equilibrium between the free flowing circulating pool and 
marginating pool (63). Remarkable fluctuations of the circulat-
ing pool occur in nearly all neonates after birth due to a surge 
in neutrophil numbers in the first 6–24 h of life to levels never 
again encountered in one’s lifetime while healthy (64). This rise 
occurs earlier in neonates ≥28 weeks of GA with peak levels of 
25–28,000 cells/μL noted around 6–12 h of life, while in those 
<28 weeks of GA experience a more gradual but dramatic rise, 
with maximum numbers of up to 40,000 cells/μL being achieved 
around 24 h of life (64). Irrespective of GA at birth, all newborns 
will subsequently undergo a gradual decline in neutrophil num-
bers over the next 72 h, with neutrophil composition and counts 
closely approximating that of adults by the third day of life (64).
Differences in neutrophil composition also exist, as term 
neonates have an increased number of IGs (promyelocytes, 
myelocytes, and metamyelocytes) when compared to adults (12 
vs. 5%, respectively) (65). The higher quantity of IGs, which are 
deficient in vital early pro-inflammatory proteins and receptors 
due to incomplete or absent development of gelatinase granules 
or secretory vesicles, may increase a neonate’s risk of infection 
after birth while simultaneously guarding against inappropriate 
inflammatory responses during the creation of its microbiome. 
Because neonates have a limited proliferative pool, neutrophils 
involved in this early surge are theorized to accrue from the 
marginating pool in response to birth-related stress hormones 
produced in the neonate, although the exact source and mecha-
nism involved remain unknown.
FUNCTiONAL DiFFeReNCeS OF 
NeONATAL NeUTROPHiLS
Microbicidal Proteins and Activity
Degranulation capabilities are similar between term neonatal 
and adult neutrophils, while those from preterm infants 
have considerable impairments in the release of bactericidal/
permeability-increasing protein (BPI), elastase, and lactoferrin 
when compared to either term neonatal or adult cells (66, 67). 
Additionally, neutrophils from term healthy newborns and adults 
contain equal concentrations of the azurophilic granule proteins 
myeloperoxidase and defensin, while BPI is decreased threefold 
in unstimulated term neonatal neutrophils compared to adult 
controls (68). Interestingly, term infants with early-onset sepsis 
(EOS) experience a rise in plasma levels of BPI comparable to 
those of older children with sepsis syndrome (69) and adults with 
bacteremia (70) or pneumonia (67, 71). In laboratory studies 
using the stimulus phorbol myristate acetate (PMA), Nupponen 
and colleagues demonstrated that term and adult neutrophils 
generated similar concentrations of BPI, while its production 
remained significantly diminished in preterm neonatal cells. 
This finding suggests that BPI mobilization within the neutrophil 
exhibits an age-dependent maturational effect (67). BPI has a 
high affinity for the lipid A portion of lipopolysaccharide (LPS; 
the endotoxin of Gram-negative bacteria), thereby neutralizing 
its pro-inflammatory properties (68, 72). BPI also enhances 
phagocytosis of Gram-negative bacterium by acting as an 
opsonin (68, 73). These factors may explain why preterm infants 
deficient in BPI mobilization are more likely to become septic 
with Gram-negative bacteria, such as Escherichia coli, the leading 
cause of EOS in preterm infants. Additionally, the specific gran-
ule protein lactoferrin has direct bacteriostatic and bactericidal 
activities against viruses, Gram-positive bacteria, Gram-negative 
bacillis, and fungi (74). Lactoferrin measured in term neonatal 
neutrophils was half of adult concentrations, while preterm cells 
had even lower quantities (75).
Galectin-3, a S-type lectin receptor, is a non-traditional neu-
trophil membrane receptor with pro-inflammatory autocrine/
paracrine effects on neutrophil phagocytosis, particularly of 
Candida species (76, 77). This receptor recognizes and binds to 
β-(1-2) oligomannan, thereby allowing the cell to distinguish 
between pathogenic and non-pathogenic fungi (76). Following 
its release extracellularly by activated or damaged neutrophils, 
galectin-3 binds to the neutrophil cell membrane. This binding 
results in the co-ligation of CD66a and CD66b, which leads to 
receptor clustering, integrin-mediated adhesion, and enhanced 
phagocytic capabilities (77). Galectin-3 has also been shown to 
increase reactive oxygen species (ROS) production, enhance 
FigURe 2 | Neutrophil recruitment and tissue extravasation. 
Chemoattractants derived from the host and/or invading pathogens activate 
quiescent neutrophils and provide a chemical gradient for stimulated 
neutrophils to hone onto and migrate toward the site of infection. Once at the 
inflamed site, initial contact between the neutrophil and vascular endothelium 
occurs during rolling and capture, which is facilitated by L-selectin on the 
neutrophil and E-selectin on the inflamed endothelium. This initial contact 
causes shedding of L-selectin and triggers the induction of lymphocyte 
function-associated antigen-1 and CR3, which establishes firm adhesion. 
Neutrophils then exit the vasculature by paracellular migration at the 
endothelial borders (70–90%) or via transcellular passage (not shown).
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neutrophil degranulation, and inhibit apoptosis (77–79). 
Although contrasting data exist regarding serum and plasma lev-
els in term neonates and adults, serum levels appear to be lower 
in preterm compared with term infants and rises throughout 
gestation (76, 80). Galectin-3 levels have also been demonstrated 
to be higher in neonates delivered vaginally compared to cesarean 
without labor, which may prime labor exposed neutrophils and 
render them more responsive to challenges with Gram-negative 
bacteria (79) or fungi (76, 80).
Chemotaxis and Migration
Neutrophils comprise the majority (60%) of leukocytes in humans 
(51) and are the “police force” of the immune system because 
they are the first immune cells to respond to and combat invading 
pathogens. During the earliest stages of infection or inflammation, 
chemoattractants derived from either the host (e.g., chemokines, 
cytokines, leukotrienes) and/or pathogen (e.g., LPS, fMLP) are 
released into the bloodstream, causing stimulation and activation 
of quiescent neutrophils. These agents also create a biochemical 
gradient that is sensed by specialized G protein-coupled recep-
tors and induce intracellular signaling cascades that result in cell 
polarization, cytoskeletal rearrangement, and adhesion molecule 
clustering. These changes are necessary to enable the activated 
neutrophil to hone in and migrate toward the site of infection in 
the process known as chemotaxis (8, 81).
Neonatal neutrophils have similar chemotactic abilities, irre-
spective of GA (63, 82), but demonstrate reduced responsiveness 
when compared to adult cells (83–87). Though the number and 
affinity of cell surface receptors are comparable, deficiencies in 
neonates are attributed to reduced mobilization of intracellular 
calcium that result in aberrations in chemoattractant-induced 
signaling (88), as well as anomalies in microfilamentous cytoskel-
etal organization from delayed F-actin induction (89). IGs are 
also inept at chemotaxis and are found in higher numbers in 
neonates after birth as compared to adults (90, 91). In general, 
though, neutrophils from term infants achieved similar chemot-
actic abilities to adult cells by around 4 weeks of age. By contrast, 
deficiencies persisted in nearly half of preterm infants at 42 weeks 
of GA for reasons that remain unclear (84, 85), indicating that 
birth and extrauterine environmental factors do not fully correct 
the developmental program of maturation.
Once the stimulated neutrophils arrive at the site of infec-
tion, extravasation into the tissue requires four mechanisms: (1) 
capture and rolling, (2) firm adhesion, (3) crawling, and (4) dia-
pedesis or transmigration (Figure 2). Initial contact between the 
neutrophil and vascular endothelium occurs during rolling and 
capture, which depends upon the interaction of L-selectin on the 
neutrophil and P- or E-selectin on the endothelium. Once contact 
is established, chemokines located on the inflamed endothelium 
bind to specific chemokine receptors on the neutrophil cell 
surface, thereby triggering a conformational change of the neu-
trophil, shedding of L-selectin (92), and induction of β2 integrin 
expression, including lymphocyte function-associated antigen 1 
(LFA-1) and CR3 (CD11b/CD18, αMβ2, MAC-1), by inside-out 
signaling (93). L-selectin is then shed from the neutrophil, and 
the β2 integrins establish firm adhesion with the endothelium 
by binding to members of the immunoglobulin superfamily of 
adhesion molecules, such as intercellular adhesion molecule 1 
and 2 (ICAM-1 and ICAM-2), vascular cell adhesion molecule 
1 (VCAM-1), and receptor for advanced glycation endproducts 
(8, 50, 60).
Neonatal neutrophils exhibit marked impairments in slow roll-
ing and adhesion. One reason is reduced expression and shedding 
of L-selectin (94). This cell membrane receptor first appears on 
neonatal neutrophils around 21 weeks of fetal development (38, 
95), and its concentration on the neutrophil cell surface increases 
in an age-dependent manner (38, 93). Although L-selectin shed-
ding improves with fetal maturation, overall quantity and ease of 
release remains far below that of adult levels at term gestation, 
with substantial deficits noted in neonates <30 weeks of GA (8, 
38, 93, 96).
Another reason for deficient slow rolling and adhesion in neo-
nates is diminished upregulation of CR3 following chemotactic 
stimulation. Intriguingly, levels of CR3 in mid-gestational aged 
neonates are similar to those of patients with leukocyte adhesion 
deficiency type 1 syndrome (38, 93). When cytosolic and cell 
membrane measurements of CR3 stores were analyzed, investiga-
tors found that neonates had only 10% of adult levels at 27 weeks 
GA, increasing to 48% at 36  weeks GA, and then to 57 ±  4% 
at term (38). Of note, adult levels of CR3 were not attained by 
neonatal neutrophils until 11  months of age (38). Conversely, 
the appearance of LFA-1 in the neutrophil cell membrane is not 
dependent on maturation, with equivalent abundance in adults 
and neonates, regardless of GA (8, 38, 97) (Table 1).
The ability of the neonatal vascular endothelium to upregulate 
its expression of adhesion molecules following exposure to LPS 
is also greatly reduced in an age-dependent manner (93, 98). 
Neonatal neutrophils also have impairments of transmigration 
through the vascular endothelium due to decreased quantities of 
CR3 and diminished release of chemokines and cytokines from 
TABLe 2 | Similarities between neonatal and adult neutrophils.
variable Preterm Term Matures Comment
Degranulation capabilities ↓ N Yes Only known for BPI, elastase, and lactoferrin (66, 67)
Granule protein levels
 Myeloperoxidase N N No (68)
 Defensin N Unknown (68)
Rolling and firm adhesion
  Lymphocyte function-
associated antigen-1 levels
N N No (8, 38, 97)
Phagocytosis ↓ N Yes Reduced in neonates with sepsis or non-infective clinical stress for some organisms (116)
 CR1 N Yes (107)
 FcγRII ↓ N Yes (108, 109)
 FcγIII ↓ N Yes Adult levels in preterm infants reached by 2 weeks of age (108)
Respiratory burst N/↑ N/↑ No Decreased in stressed neonates or those with perinatal distress (134)
Chemiluminescence N/↓ N/↑ No Reduced in critically ill neonates and those challenged with large bacterial loads (139, 142)
N, normal; ↑, increased; ↓, decreased.
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tissue neutrophils and macrophages (47, 99). Thus, only about 
half as many term neonatal neutrophils transmigrate through the 
vascular endothelium in response to infection or inflammation 
when compared to adult cells (38).
Infant health has also been shown to affect chemotaxis. 
Remarkably, neonates who are ventilated for severe respira-
tory distress syndrome (but otherwise healthy) (84) and those 
with superficial infections (100) had neutrophils that exhibit 
enhanced chemotactic abilities when compared to those of stable 
preterm and term infants (84). Conversely, septic infants with 
Gram-negative bacteremia had poorly chemotactic neutrophils 
(82, 100). Likewise, intrapartum exposure to magnesium sulfate 
reduced neonatal neutrophil chemotactic abilities with impair-
ment directly correlated with maternal serum magnesium levels 
(101), and insufficiencies related to antenatal betamethasone 
exposure were attributed to reductions in endothelial expres-
sion of adhesion molecules, including E-selectin, ICAM-1, and 
VCAM-1 (102).
Phagocytosis
Neutrophils generally exit the vasculature by paracellular migra-
tion at the endothelial borders (70–90%), but a few will travel 
through the endothelial cell via a transcellular passage (103). 
Once within the tissue, oxygen deprivation created by the 
pathological conditions of the infection drives HIF-dependent 
activation of prosurvival pathways in the neutrophil (104, 105) to 
enhance its bactericidal activity (106). Neutrophils then continue 
to migrate along the chemotactic gradient toward the site of 
microbial invasion. When encountered, neutrophils engulf the 
pathogens using receptors for complement and the Fc domain of 
immunoglobulins, including CR1, CR3, FcγRII, and FcγIII (38). 
While the number of CR1 (107) and both Fcγ receptors (108) 
are the same between term neonates and adults, CR3 receptors 
are decreased as previously discussed (38, 109). Conversely, 
preterm infants at birth express 80–88% of adult levels of FcγRII 
but only 50% of FcγIII (109). FcγIII levels, however, rise rapidly 
postnatally to reach adult levels by 2 weeks of life. Together, these 
four receptors mediate binding, ingestion, and killing of bacteria 
(38) (Table 2).
Neonatal neutrophils from term, healthy infants opsonize 
and ingest both Gram-negative (91, 110) and Gram-positive 
bacteria with equivalent efficiency to adult cells (111). By 
contrast, phagocytosis was less proficient in preterm infants 
<33  weeks of GA, who experienced both slower uptake and 
ingestion of bacteria compared to term neonates and adults. 
Curiously, these impairments persisted at 1–2 months of age, 
despite no apparent maturational defect (112). These deficits 
are believed to result from low circulating levels of opsoniza-
tion factors, particularly maternal immunoglobulins that are 
actively transported across the placenta in the last trimester of 
pregnancy. Supportive evidence comes from the observation 
that administration of intravenous immunoglobulins (IVIG) 
normalizes phagocytosis capacity in preterm infants <32 weeks 
of GA (113). The use of IVIG in the treatment of neonatal 
sepsis, however, failed to reduce either (1) mortality during the 
hospital stay or (2) death or major disability at 2 years of age 
in infants with suspected or proven sepsis in a large cohort of 
neonates (114, 115). In the face of infective or non-infective 
clinical stress, the ability of neonatal neutrophils to phagocy-
tose Gram-positive bacteria remained intact, but was impaired 
for Gram-negative bacteria (116).
Conversely, phagocytosis of Candida not only depends upon 
the size and form of the pathogen (i.e., hyphae or yeast) but also 
upon the species (76, 117). Destin and coworkers concluded 
that neutrophils from preterm and term infants as well as 
adult controls all failed to phagocytose unopsonized Candida 
albicans yeast, yet were similarly capable of phagocytosing 
unopsonized Candida parapsilosis (77, 117). Likewise, oxida-
tive burst was equally robust when challenged with C. albicans 
hyphae in all groups, but non-existent against C. parapsilosis 
and attenuated against C. albicans yeast forms (117). Others 
have also demonstrated reduced phagocytosis and killing of C. 
albicans by preterm neonatal neutrophils due to deficiencies 
of opsonization factors (66, 118–120). Likewise, galectin-3, 
mentioned earlier in this review, is critical for the neutrophil’s 
ability to recognize, engulf, and kill pathogenic Candida spe-
cies. This finding is most likely due to the ability of galectin-3 
to co-ligate neutrophil cell membrane receptors CD66a and 
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CD66b, resulting in cell receptor clustering and integrin-
mediated adhesion (77). Galectin-3 also primes/activates the 
neutrophil, thereby enhancing ROS production, prolonging cell 
survival, and increasing degranulation of microbicidal proteins 
and substances (77).
Phagocytosis-Associated Respiratory 
Burst and Chemiluminescence (CL)
Microorganisms, engulfed by neutrophils, are trapped within 
phagosomes that fuse with azurophilic and specific granules to 
form phagolysosomes, which are small, confined spaces designed 
for toxic, oxidative reactions vital in destroying pathogens while 
protecting the host tissue against harmful metabolites (121, 122). 
The formation of phagolysosomes is associated with an increase 
in hexose monophosphate shunt metabolism of glucose and, in 
turn, a proportional rise in molecular oxygen consumption that 
is known as the respiratory burst (121). NADPH oxidase, local-
ized on the membrane of the phagolysosome, is also activated by 
phagocytosis and is essential in driving the respiratory burst via 
the reduction of oxygen (O2) to yield hydroxydioxylic acid (HO2) 
and hydrogen peroxide (H2O2) (121, 123). Inactivating mutations 
in NADPH oxidase result in chronic granulomatous disease 
(CGD), which is characterized by recurrent bacterial and fungal 
infections, as well as granulomas that result from the neutrophils’ 
inability to completely kill and eliminate pathogens (124). HO2 
and H2O2 are weakly bactericidal (125) and lead to considerable 
acidification of the phagolysosome (95, 121). Myeloperoxidase, 
also released from azurophilic granules, catalyzes oxidation reac-
tions between H2O2 and chloride (Cl−) to form hypochlorous acid 
(HOCl) (126), hydroxyl radicals (⋅OH), and chloramines, all of 
which are potent oxidants (127) that further contribute to the 
microbicidal capabilities of neutrophils (125). The resulting reac-
tions between microorganisms and oxygenation radicals produce 
electronic excited products that cause light emission in the visible 
spectrum, known as CL (128).
The generation of O2
− can be detected using the nitroblue 
tetrazolium (NBT) test (129), which remains negative (clear) in 
patients with CGD, but produces a positive (or blue) reaction in 
neutrophils from healthy term newborns. Neonatal neutrophils 
induce an intensely positive reaction that corresponds to enhanced 
oxygen consumption in the initial phase of the respiratory burst 
and normal or elevated production of H2O2 (130). The NBT is 
also more intense from cord blood neutrophils exposed to labor 
than those without, suggesting that parturition primed these 
cells for increased activity (131, 132). Quantitative differences 
in the kinetic activity of the neonatal NADPH oxidase system 
may explain variances in NBT results (131, 133). Comparable 
bactericidal activity has been demonstrated between healthy neo-
natal and adult neutrophils toward Staphylococcus aureus, E. coli, 
Serratia marcescens, Pseudomonas species, and groups A and B 
streptococci (127), while neutrophils from stressed preterm and 
term infants demonstrated significantly decreased bactericidal 
activity against both Gram-positive and Gram-negative bacteria 
(127). Neutrophils from neonates with perinatal distress also 
exhibited respiratory burst suppression (134–136). Even though 
the respiratory burst normalized to adult cellular function in 
preterm infants by 2 months of age, it remained depressed in ill 
infants receiving intensive care (137).
The interaction between ROS and microorganisms is the foun-
dation of CL. In healthy, term neonates, CL is normal or enhanced 
for group B Streptococcus (GBS) and opsonized zymosan (111, 
138) but is generally dampened in neutrophils from healthy pre-
term neonates <34 weeks of GA (111, 130, 134, 139). Moreover, 
critically ill preterm or term infants have significantly reduced 
CL (140), as do neutrophils challenged with large bacterial loads 
(141). Although neonatal deficiencies in CL persist throughout 
the course of serious infection, it tends to normalize to adult 
levels by 2 months after birth (142).
Neutrophil extracellular Traps (NeTs)
By extruding chromatin material loaded with antimicrobial mol-
ecules including citrullinated histones, elastase, myeloperoxidase, 
lactoferrin, and defensins extracellularly (143) through forma-
tion of NETs, neutrophils can entrap and kill bacteria, fungi, and 
protozoa (144). Neutrophils can produce NETs by two distinct 
pathways. The first is initiated in response to LPS, TNF-α, or 
IL-8 (145, 146) and requires activation of NADPH oxidase (147), 
ROS production (148, 149), and induction of the RIPK3–MLKL 
cascade (150, 151). Neonatal neutrophils from term and preterm 
infants fail to form NETs in this manner, even though they have 
the ability to generate endogenous ROS and have NADPH activity 
equivalent to adult cells (152). Hence, Lipp and coworkers dem-
onstrated significantly less NET formation, with reduced NET 
area, from neonatal cord blood neutrophils compared to adult 
cells following stimulation with N-formylmethionine-leucyl-
phenylalanine (fMLP), PMA, and LPS, with even lower numbers 
and NET area noted in preterm neonatal neutrophils (153). This 
may be due to NET-inhibitory factors (nNIF) or nHIF-related 
peptides, which appear to be unique to neonatal neutrophils 
and function as important regulators of fetal and neonatal 
inflammation (154).
Neonatal neutrophils, irrespective of GA at birth, produce 
NETs via the second, ROS-independent pathway after exposure 
to certain pathogens and following activation by the complement 
system (155, 156), TLR2, and/or fibronectin (150). Byrd and col-
leagues recently demonstrated that preterm and term infants as 
well as adult controls produced NETs equally well when exposed 
to fibronectin together with either purified β-glucan or C. albicans 
hyphae in a ROS-independent manner but did not form NETs 
when exposed to fibronectin or β-glucan independently (157).
NeUTROPHiLS AND THe MiCROBiOMe
During parturition, the once naïve fetus passes through the 
vaginal canal where it is exposed to trillions of microorganisms 
that comprise the maternal microbiota. Neutrophil tolerance is 
imperative during this period to prevent the induction of pro-
inflammatory reactions as the newborn is colonized with com-
mensal microbes that harbor a variety of nucleic acids, proteins, 
and antigens. Once established, a symbiotic relationship is created 
between the host microbiota and neutrophils to ensure proper 
neutrophil function and numbers. Interventions that hinder 
the natural development of the newborn’s microbiota, such as 
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cesarean delivery or exposure to intrapartum and/or postpartum 
antibiotics, may place the infant at an increased risk for late-onset 
sepsis, necrotizing enterocolitis, prolonged length of stay, and/
or death (4, 158, 159). Recent discoveries by Deshmukh and 
colleagues help explain this association. Using a murine model, 
this group demonstrated that the pup microbiota induced IL-17 
production by group 3 innate lymphoid cells in the intestine, 
which increased G-CSF and, hence, neutrophil production in a 
TLR-4- and MyD88-dependent manner (160). This interaction 
also increases the number of aged circulating neutrophils in 
adult mice, which possess enhanced αMB2 integrin and are more 
proficient at NET production under inflammatory conditions 
(161). Similar studies on aging neutrophils, however, are lacking 
in neonatal models.
NeONATAL NeUTROPHiLS AND 
iMMUNOLOgiC QUID PRO QUO
After birth, cord blood neutrophils appear “primed” because 
they demonstrate increased concentrations of pro-inflammatory 
chemokines and cytokines, as well as experience prolonged 
survival secondary to deficient programmed apoptosis (162). 
Shortages of crucial cell membrane receptors, diminished intra-
cellular signaling, and impaired cellular functioning, however, 
can result in neutrophil dysfunction leading to increased sus-
ceptibility to sepsis, tissue damage, and shock. Well-documented 
examples of enhanced neutrophil inflammatory responses with 
associated inhibitory mechanisms are outlined below.
Unstimulated cord blood neutrophils from term, healthy 
neonates have higher concentrations of pro-inflammatory 
cytokines such as IL-1β, TNF-α, and IFN-γ compared to adult 
controls, irrespective of labor exposure (91). In addition, neona-
tal neutrophils experience heightened IL-1β expression follow-
ing stimulation by TNF-α and LPS as compared to adult cells 
(163). When toll-like receptors (TLRs) 1–9 are directly stimu-
lated, however, neonatal neutrophils exhibit a global decrease 
in the production of these TH1-polarizing cytokines, which are 
vital in protecting the newborn against intracellular viral and 
bacterial infections. Instead, neonatal neutrophils secrete greater 
amounts of TH2-polarizing cytokines, including IL-6 and IL-10, 
which are adapted to defend against parasitic infections but can 
also increase the newborn’s future risk of developing atrophy, 
allergy, and asthma (9, 164, 165). The reasons for their decreased 
responsiveness to TH1-mediated responses may include reduced 
intracellular mediators of TLR signaling (166) or increased levels 
of plasma adenosine (9).
It has been proposed that adenosine, by binding G 
protein-coupled A3 adenosine receptors (A3ARs), increases 
intracellular cAMP levels, thereby preserving generation of 
TH2-polarizing cytokines, including IL-6, which have anti-
inflammatory properties and can impede neutrophil migration 
to site of inflammation (9). It is known, however, that A3ARs 
couple to the G protein Gi, which inhibits adenylyl cyclase 
and lowers cellular cAMP levels (167). Thus, it is possible that 
alternate G protein coupling may occur in neutrophils or that 
adenosine may facilitate IL-6 generation through a different 
member of this receptor family. Although adenosine suppresses 
neutrophil cell membrane levels of CD11b in neonatal and 
adult neutrophils, their ability to phagocytose microorganisms 
remains unaffected. Unlike adult cells (168, 169), however, 
adenosine does not alter chemotaxis or production of ROS by 
neonatal neutrophils (170). Nonetheless, adenosine increases 
susceptibility to infection by intracellular pathogens through 
TH2-polaring pathways while facilitating colonization of 
commensal microorganisms after birth by limiting excessive 
inflammation.
As previously noted, cell membrane levels of galectin-3 are 
greatly increased in neonatal compared to adult neutrophils (80). 
Additionally, unstimulated neonatal cells also produced larger 
amounts of the potent chemoattractant IL-8 (171). Following labor 
exposure, both galectin-3 and IL-8 concentrations are notably 
higher in neonatal neutrophils, leading investigators to conclude 
that fetal neutrophils reside in a “pre-primed” state and become 
reactive following labor. When stimulated with LPS, however, no 
differences in neutrophil galectin-3 or IL-8 levels were found, 
whether or not the neonate was exposed to labor. Importantly, 
neonatal neutrophils also did not demonstrate improved 
L-selectin shedding (80). Yost and colleagues also showed similar 
lack of upregulation of pro-inflammatory mediators after TLR 
1–9 stimulation but did demonstrate elevated IL-8 levels using 
the TLR1/2 heterodimer agonist, PAM3CSK4 (172). While not 
directly tested in neutrophils, TLR 1/2 activation by PAM3CSK4 in 
monocytes is associated with significantly increased production 
of IL-10 (173), thereby blunting pro-inflammatory TH1 reactions 
in favor of TH2 immune responses. Thus, elevated levels of IL-8 
should result in the recruitment of additional activated neutro-
phils to area of inflammation or infection, amplifying the acute 
inflammatory response with the potential to propagate local tissue 
damage. Without the shedding of L-selectin, however, neutro-
phils experience impaired rolling, firm adhesion, and endothelial 
transmigration, limiting their accumulation in inflamed tissue. 
Nonetheless, this dysregulated local response may lead to tissue 
damage that could result in chronic lung disease or necrotizing 
enterocolitis, although more research is needed to investigate this 
association in vivo (169, 174).
Neonatal neutrophils also have exaggerated pro-inflammatory 
responses to the major cell component of Gram-positive bacteria, 
peptidoglycan. Exposure to peptidoglycan stimulates neonatal 
neutrophil expression of CD11b, TNF-α, and IL-8, which improves 
chemotaxis capabilities and increases ROS production. These 
actions are facilitated via heat shock proteins, including HSPA1A 
and OLR1 (175). Conversely, CR3 (CD11b/CD18, MAC-1), 
an essential pathogen recognition receptor for Gram-negative 
bacteria, can bind LPS, thereby enhancing neutrophil phagocytic 
capabilities of these microorganisms. At baseline, however, cell 
membrane quantities of CR3 are decreased in neonatal cells, 
particularly in preterm infants, which may impair their ability 
to detect Gram-negative pathogens. Furthermore, once activated, 
neonatal neutrophil CR3 levels remain reduced compared to 
adult cells, which not only inhibits neutrophil activation but may 
also limit their accumulation at sites of inflammation (97).
Group B Streptococcus remains the leading cause of neonatal 
EOS and can elicit variable immunologic responses in the host. 
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For example, GBS hemolysin and inflammasome components 
can trigger pro-IL-1β processing and IL-1β release by neonatal 
neutrophils, amplifying their recruitment to sites of infection 
(176). Alternatively, molecular mimicry by GBS capsular sialic 
acid and β protein attenuates innate immune responses by 
binding to inhibitory sialic acid-binding immunoglobulin-like 
lectin receptors (Siglecs) on neutrophils, triggering SHP-2 
phosphatase-dependent signaling to impede neutrophil activa-
tion and phagocytic killing (177, 178). Finally, GBS can induce 
IL-10 production in murine pups compared to adult animals, 
which impairs neutrophil recruitment to inflamed tissues and 
reduces bacterial clearance. Attenuation of this response, how-
ever, is exhibited by TLR2-deficient murine pups, which experi-
ence improved survival by limiting GBS bacterial dissemination 
through enhanced GBS phagocytosis (179).
Anti-inflammatory neutrophil granular proteins, such as 
olfactomedin-4 located in specific granules, can also attenuate 
neutrophil bacterial killing and host innate immunity against 
Gram-negative and Gram-positive bacteria (180). Its expression is 
significantly upregulated in unstimulated cord blood neutrophils 
from healthy term newborns compared to adult cells (91) and 
levels are dramatically higher in septic neonates (181). OLFM-4 
restricts neutrophil cathespsin c-mediated protease activity and 
Nod-like receptor-mediated NF-κB activation, thereby restrict-
ing antimicrobial killing (180). Elevated OLFM-4 expression is 
associated not only with decreased levels of IL-1β, IL-6, IL-12p40, 
CXCL2, G-CSF, and GM-CSF but also with greatly increased 
sepsis-related mortality (180, 182).
Finally, bacterial and host pro-inflammatory mediators can 
prolong neutrophil survival by delaying apoptosis. While this 
response is crucial for competent early innate immune responses 
that facilitate bacterial clearance, it may also promote excessive 
tissue injury resulting in poor neonatal outcomes (183). Allgaier 
and colleagues (184) have demonstrated that the overexpression 
of IL-1β and IL-8 cause activation of NF-κB and induction of 
anti-apoptotic genes. Additionally, neonatal neutrophils have 
diminished cellular expression of Siglec-9 and its downstream 
signaling protein SHP-1, an inhibitory tyrosine phosphate with 
proapoptotic functions (185). Inflammation resolution and tissue 
repair are generally facilitated by removal of toxic neutrophils 
through pathogen-induced programmed cell death via apoptosis 
with subsequent clearance by tissue macrophages and mono-
cytes. The consequences of delayed neutrophil apoptosis and 
turnover are clearly demonstrated by Grigg and colleagues (186) 
who showed direct correlation with higher rates of chronic lung 
disease and pulmonary injury.
CONCLUSiON
Annually, an estimated 400,000 neonates, or 1 in 10 newborns, 
are born prematurely in the United States (187, 188), and 
prematurity-related health issues account for an astonishing 
36% of all infant deaths (189). Infectious disease is the second 
leading cause of neonatal mortality worldwide, preceded only 
by complications related to preterm birth (190). Technological 
advancements in ventilator management, thermoregulation, 
nutrition, and medical therapies (such as surfactant) have 
permitted survival of extremely preterm infants to the limits of 
viability, now considered 22–23 weeks of GA or slightly beyond 
the halfway point of normal gestation. Nature, however, did 
not intend fetal survival outside the womb at this young age as 
evidenced by the underdevelopment of all organ systems, which 
increases the neonate’s risk for infection, intraventricular hem-
orrhage, retinopathy of prematurity, patent ductus arteriosus, 
necrotizing enterocolitis, chronic lung disease, and impaired 
neurodevelopmental outcomes. While adaptive responses are 
generally deficient, certain aspects of innate immunity may be 
absent, including the vernix that develops around 28 weeks’ GA 
and the stratum corneum in the third trimester (191). As with 
other organ systems, postnatal neutrophil deficits are exacerbated 
in the most immature neonates, resulting in a 10-fold greater risk 
for early infection compared to term infants and 30% mortality 
rate in those infected (191–194).
Neonatal neutrophils have been extensively studied and are 
often inappropriately characterized as “dysfunctional” when 
compared to adult cells. Because considerable differences 
between fetal and adult physiology exist, phenotypic and func-
tional variances are vital. Neonatal neutrophils have adapted 
and evolved over time to endure extremely hypoxic in  utero 
environmental conditions without triggering HIF-1α-mediated 
pro-inflammatory responses (195–197). Furthermore, neutro-
phil suppression is essential for the naïve newborn to establish a 
healthy microbiome in the postpartum period, but detrimental if 
unable to mount sufficient pro-inflammatory reactions if exposed 
to pathogenic organisms.
The evolution of laboratory techniques over the last 50 years 
has enabled researchers to substantially expand our knowledge 
of neutrophil biology. Neutrophils are no longer viewed as 
short-lived, indiscriminate phagocytes of the immune system, 
but instead as essential components necessary for proper B 
and T cell function, antigen presentation, and tissue repair and 
regeneration. Differences in laboratory methods and variations 
in neonatal populations over time may make comparisons 
between past and present data difficult and yield potentially 
contrasting results. The rapid evolution of neonatal care, from its 
first appearance in the 1960s to the present, may also challenge 
current concepts of neonatal neutrophil biology as younger, 
sicker babies are resuscitated, pushing the limits of viability to 
even lower GAs. As scientists continuously strive to discover 
novel therapies to enhance neutrophil function during neonatal 
sepsis, efforts and resources must also be dedicated to unrave-
ling the mysteries of neutrophil biology during fetal develop-
ment, taking into account environmental and compositional 
influences.
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